Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.

Smith R, Pioro E, Myers K, Sirdofsky M, Goslin K, Meekins G, Yu H, Wymer J, Cudkowicz M, Macklin EA, Schoenfeld D, Pattee G.

Neurotherapeutics. 2017 Mar 10. doi: 10.1007/s13311-017-0517-z. [Epub ahead of print] No abstract available.

PMID:
28283968
2.

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.

Smith R, Pioro E, Myers K, Sirdofsky M, Goslin K, Meekins G, Yu H, Wymer J, Cudkowicz M, Macklin EA, Schoenfeld D, Pattee G.

Neurotherapeutics. 2017 Jan 9. doi: 10.1007/s13311-016-0508-5. [Epub ahead of print] Erratum in: Neurotherapeutics. 2017 Mar 10;:.

PMID:
28070747
3.

Case report of vasovagal syncope associated with single pulse transcranial magnetic stimulation in a healthy adult participant.

Gillick BT, Rich T, Chen M, Meekins GD.

BMC Neurol. 2015 Dec 1;15:248. doi: 10.1186/s12883-015-0510-2.

4.

Synergistic effect of combined transcranial direct current stimulation/constraint-induced movement therapy in children and young adults with hemiparesis: study protocol.

Gillick B, Menk J, Mueller B, Meekins G, Krach LE, Feyma T, Rudser K.

BMC Pediatr. 2015 Nov 12;15:178. doi: 10.1186/s12887-015-0498-1.

5.

Genome-wide meta-analysis of myopia and hyperopia provides evidence for replication of 11 loci.

Simpson CL, Wojciechowski R, Oexle K, Murgia F, Portas L, Li X, Verhoeven VJ, Vitart V, Schache M, Hosseini SM, Hysi PG, Raffel LJ, Cotch MF, Chew E, Klein BE, Klein R, Wong TY, van Duijn CM, Mitchell P, Saw SM, Fossarello M, Wang JJ; DCCT/EDIC Research Group., Polašek O, Campbell H, Rudan I, Oostra BA, Uitterlinden AG, Hofman A, Rivadeneira F, Amin N, Karssen LC, Vingerling JR, Döring A, Bettecken T, Bencic G, Gieger C, Wichmann HE, Wilson JF, Venturini C, Fleck B, Cumberland PM, Rahi JS, Hammond CJ, Hayward C, Wright AF, Paterson AD, Baird PN, Klaver CC, Rotter JI, Pirastu M, Meitinger T, Bailey-Wilson JE, Stambolian D.

PLoS One. 2014 Sep 18;9(9):e107110. doi: 10.1371/journal.pone.0107110.

6.

Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes.

Sarma AV, Hotaling J, Dunn RL, Cleary PA, Braffett BH, Kim C, Martin C, Herman W, Gatcomb P, Jacobson AM, Holt SK, Wessells H; DCCT/EDIC Research Group..

J Urol. 2015 Mar;193(3):786-93. doi: 10.1016/j.juro.2014.08.115.

7.

Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.

Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, Lorenzi G, Zinman B; DCCT/EDIC Research Group..

Diabetes. 2013 Dec;62(12):3976-86. doi: 10.2337/db13-1093. No abstract available.

8.

Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error.

Cheng CY, Schache M, Ikram MK, Young TL, Guggenheim JA, Vitart V, MacGregor S, Verhoeven VJ, Barathi VA, Liao J, Hysi PG, Bailey-Wilson JE, St Pourcain B, Kemp JP, McMahon G, Timpson NJ, Evans DM, Montgomery GW, Mishra A, Wang YX, Wang JJ, Rochtchina E, Polasek O, Wright AF, Amin N, van Leeuwen EM, Wilson JF, Pennell CE, van Duijn CM, de Jong PT, Vingerling JR, Zhou X, Chen P, Li R, Tay WT, Zheng Y, Chew M; Consortium for Refractive Error and Myopia., Burdon KP, Craig JE, Iyengar SK, Igo RP Jr, Lass JH Jr; Fuchs' Genetics Multi-Center Study Group., Chew EY, Haller T, Mihailov E, Metspalu A, Wedenoja J, Simpson CL, Wojciechowski R, Höhn R, Mirshahi A, Zeller T, Pfeiffer N, Lackner KJ; Wellcome Trust Case Control Consortium 2., Bettecken T, Meitinger T, Oexle K, Pirastu M, Portas L, Nag A, Williams KM, Yonova-Doing E, Klein R, Klein BE, Hosseini SM, Paterson AD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions, and Complications Research Group., Makela KM, Lehtimaki T, Kahonen M, Raitakari O, Yoshimura N, Matsuda F, Chen LJ, Pang CP, Yip SP, Yap MK, Meguro A, Mizuki N, Inoko H, Foster PJ, Zhao JH, Vithana E, Tai ES, Fan Q, Xu L, Campbell H, Fleck B, Rudan I, Aung T, Hofman A, Uitterlinden AG, Bencic G, Khor CC, Forward H, Pärssinen O, Mitchell P, Rivadeneira F, Hewitt AW, Williams C, Oostra BA, Teo YY, Hammond CJ, Stambolian D, Mackey DA, Klaver CC, Wong TY, Saw SM, Baird PN.

Am J Hum Genet. 2013 Aug 8;93(2):264-77. doi: 10.1016/j.ajhg.2013.06.016.

9.
10.

The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.

Orchard TJ, Lyons TJ, Cleary PA, Braffett BH, Maynard J, Cowie C, Gubitosi-Klug RA, Way J, Anderson K, Barnie A, Villavicencio S; DCCT/EDIC Research Group..

Diabetes Care. 2013 Oct;36(10):3146-53. doi: 10.2337/dc12-2661.

11.

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

DCCT/EDIC Research Group., de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B.

N Engl J Med. 2011 Dec 22;365(25):2366-76. doi: 10.1056/NEJMoa1111732.

12.

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group., Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ.

Arch Intern Med. 2009 Jul 27;169(14):1307-16. doi: 10.1001/archinternmed.2009.193.

13.
14.

Drug therapy in amyotrophic lateral sclerosis.

Distad BJ, Meekins GD, Liou LL, Weiss MD, Carter GT, Miller RG.

Phys Med Rehabil Clin N Am. 2008 Aug;19(3):633-51, xi-xii. doi: 10.1016/j.pmr.2008.04.005. Review.

PMID:
18625421
15.

Axonal degeneration in the Trembler-j mouse demonstrated by stimulated single-fiber electromyography.

Meekins GD, Carter GT, Emery MJ, Weiss MD.

Muscle Nerve. 2007 Jul;36(1):81-6.

PMID:
17443662
16.

Hypoglossal neuropathy in Lewis-Sumner syndrome masquerading as motor neuron disease.

Weiss MD, Oakley JC, Meekins GD.

Neurology. 2006 Jul 11;67(1):175-6. No abstract available.

PMID:
16832106
17.

Electrodiagnostic studies in a murine model of demyelinating Charcot-Marie-Tooth disease.

Meekins GD, Weiss MD.

Phys Med Rehabil Clin N Am. 2005 Nov;16(4):967-79, ix. Review. No abstract available.

PMID:
16214054
18.

Yoga neuropathy. A snoozer.

Walker M, Meekins G, Hu SC.

Neurologist. 2005 May;11(3):176-8.

PMID:
15860140
19.

Nerve conduction abnormalities in the trembler-j mouse: a model for Charcot-Marie-Tooth disease type 1A?

Meekins GD, Emery MJ, Weiss MD.

J Peripher Nerv Syst. 2004 Sep;9(3):177-82.

PMID:
15363066
20.

Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes.

Street VA, Meekins G, Lipe HP, Seltzer WK, Carter GT, Kraft GH, Bird TD.

Neuromuscul Disord. 2002 Oct;12(7-8):643-50.

PMID:
12207932

Supplemental Content

Loading ...
Support Center